M Ogren1, B Hedblad, G Engström, L Janzon. 1. Department of Community Medicine, Division of Epidemiology, Lund University, Malmö University Hospital, Malmö, Sweden. mats.ogren@astrazeneca.com
Abstract
OBJECTIVE: To assess the prevalence of asymptomatic peripheral arterial disease (PAD) in older men with diabetes and to compare the incidence of cardiac events and deaths in diabetic and non-diabetic men with abnormal and normal systolic ankle-brachial pressure index, respectively. RESEARCH DESIGN AND METHODS: Population-based cohort of 68-year-old men (n = 474). Diabetes was defined as history of diabetes or a fasting blood glucose > or = 6.1 mmol/l. PAD was defined as an ankle-brachial pressure index (ABI) < 0.9 in either leg. Fourteen-year mortality and cardiac event rates were based on record linkage with regional and national registers. RESULTS: The prevalence of PAD in men with and without diabetes was 29 and 12%, respectively (p = 0.003). The incidence of cardiac events was 22.9/1000 person years in men free from both diabetes and PAD. In the absence of an abnormal pressure index, diabetes was associated with an event rate of 28.4 (p = 0.469). In the presence of an abnormal index the incidence was 102 (p < 0.001). This pattern remained in the multivariate analysis when other atherosclerotic risk factors were taken into account. Cardiovascular mortality rates similarly differed substantially between diabetic men with and without PAD. CONCLUSIONS: A fasting blood glucose value above 6.1 mmol/l even in the absence of symptoms indicating diabetes was associated by an increased prevalence of asymptomatic PAD. The cardiovascular risk in diabetes varied widely between men with and without abnormal ankle-brachial pressure index.
OBJECTIVE: To assess the prevalence of asymptomatic peripheral arterial disease (PAD) in older men with diabetes and to compare the incidence of cardiac events and deaths in diabetic and non-diabeticmen with abnormal and normal systolic ankle-brachial pressure index, respectively. RESEARCH DESIGN AND METHODS: Population-based cohort of 68-year-old men (n = 474). Diabetes was defined as history of diabetes or a fasting blood glucose > or = 6.1 mmol/l. PAD was defined as an ankle-brachial pressure index (ABI) < 0.9 in either leg. Fourteen-year mortality and cardiac event rates were based on record linkage with regional and national registers. RESULTS: The prevalence of PAD in men with and without diabetes was 29 and 12%, respectively (p = 0.003). The incidence of cardiac events was 22.9/1000 person years in men free from both diabetes and PAD. In the absence of an abnormal pressure index, diabetes was associated with an event rate of 28.4 (p = 0.469). In the presence of an abnormal index the incidence was 102 (p < 0.001). This pattern remained in the multivariate analysis when other atherosclerotic risk factors were taken into account. Cardiovascular mortality rates similarly differed substantially between diabeticmen with and without PAD. CONCLUSIONS: A fasting blood glucose value above 6.1 mmol/l even in the absence of symptoms indicating diabetes was associated by an increased prevalence of asymptomatic PAD. The cardiovascular risk in diabetes varied widely between men with and without abnormal ankle-brachial pressure index.
Authors: Claudia R L Cardoso; Juliana V Melo; Guilherme C Salles; Nathalie C Leite; Gil F Salles Journal: Diabetologia Date: 2018-08-15 Impact factor: 10.122
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: J Am Coll Cardiol Date: 2019-03-17 Impact factor: 24.094
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: J Am Coll Cardiol Date: 2019-03-17 Impact factor: 24.094
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: Circulation Date: 2019-03-17 Impact factor: 29.690
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: Circulation Date: 2019-03-17 Impact factor: 29.690
Authors: Nordin M J Hanssen; Maya S Huijberts; Casper G Schalkwijk; Giel Nijpels; Jacqueline M Dekker; Coen D A Stehouwer Journal: Diabetes Care Date: 2012-06-14 Impact factor: 19.112
Authors: Christopher E Clark; Fiona C Warren; Kate Boddy; Sinead T J McDonagh; Sarah F Moore; John Goddard; Nigel Reed; Malcolm Turner; Maria Teresa Alzamora; Rafel Ramos Blanes; Shao-Yuan Chuang; Michael Criqui; Marie Dahl; Gunnar Engström; Raimund Erbel; Mark Espeland; Luigi Ferrucci; Maëlenn Guerchet; Andrew Hattersley; Carlos Lahoz; Robyn L McClelland; Mary M McDermott; Jackie Price; Henri E Stoffers; Ji-Guang Wang; Jan Westerink; James White; Lyne Cloutier; Rod S Taylor; Angela C Shore; Richard J McManus; Victor Aboyans; John L Campbell Journal: Hypertension Date: 2020-12-21 Impact factor: 10.190
Authors: Felipe José de Andrade Falcão; Cláudia Maria Rodrigues Alves; Adriano Caixeta; Leonardo de Freitas Guimarães; Juscélio Trajano de Sousa Filho; Juliana A Soares; Izo Helber; Antônio C Carvalho Journal: Clin Interv Aging Date: 2013-12-02 Impact factor: 4.458